applications of molecular imprinting technology to immunoassays roger l. bertholf, ph.d. associate...
TRANSCRIPT
![Page 1: Applications of Molecular Imprinting Technology to Immunoassays Roger L. Bertholf, Ph.D. Associate Professor of Pathology University of Florida Health](https://reader036.vdocument.in/reader036/viewer/2022070307/551a4e4d550346545e8b54e4/html5/thumbnails/1.jpg)
Applications of Molecular Imprinting Technology to Immunoassays
Applications of Molecular Imprinting Technology to Immunoassays
Roger L. Bertholf, Ph.D.
Associate Professor of Pathology
University of Florida Health Science Center/Jacksonville
![Page 2: Applications of Molecular Imprinting Technology to Immunoassays Roger L. Bertholf, Ph.D. Associate Professor of Pathology University of Florida Health](https://reader036.vdocument.in/reader036/viewer/2022070307/551a4e4d550346545e8b54e4/html5/thumbnails/2.jpg)
Early theories of antibody formationEarly theories of antibody formation
• Paul Ehrlich (1854-1915) proposed that antigen combined with pre-existing side-chains on cell surfaces.
• Ehrlich’s theory was the basis for the “genetic theory” of antibody specificity.
• Paul Ehrlich (1854-1915) proposed that antigen combined with pre-existing side-chains on cell surfaces.
• Ehrlich’s theory was the basis for the “genetic theory” of antibody specificity.
![Page 3: Applications of Molecular Imprinting Technology to Immunoassays Roger L. Bertholf, Ph.D. Associate Professor of Pathology University of Florida Health](https://reader036.vdocument.in/reader036/viewer/2022070307/551a4e4d550346545e8b54e4/html5/thumbnails/3.jpg)
The “Template” theory of antibody formationThe “Template” theory of antibody formation
• Karl Landsteiner (1868-1943) was most famous for his discovery of the A/B/O blood groups and the Rh factor.
• Established that antigenic specificity was based on recognition of specific molecular structures; he called these “haptens”; formed the basis for the “template” theory of antibody formation.
• Karl Landsteiner (1868-1943) was most famous for his discovery of the A/B/O blood groups and the Rh factor.
• Established that antigenic specificity was based on recognition of specific molecular structures; he called these “haptens”; formed the basis for the “template” theory of antibody formation.
![Page 4: Applications of Molecular Imprinting Technology to Immunoassays Roger L. Bertholf, Ph.D. Associate Professor of Pathology University of Florida Health](https://reader036.vdocument.in/reader036/viewer/2022070307/551a4e4d550346545e8b54e4/html5/thumbnails/4.jpg)
History of molecular imprintingHistory of molecular imprinting
• Linus Pauling (1901-1994) first suggested the possibility of artificial antibodies in 1940
• Imparted antigen specificity on native globulin by denaturation and incubation with antigen.
• Linus Pauling (1901-1994) first suggested the possibility of artificial antibodies in 1940
• Imparted antigen specificity on native globulin by denaturation and incubation with antigen.
![Page 5: Applications of Molecular Imprinting Technology to Immunoassays Roger L. Bertholf, Ph.D. Associate Professor of Pathology University of Florida Health](https://reader036.vdocument.in/reader036/viewer/2022070307/551a4e4d550346545e8b54e4/html5/thumbnails/5.jpg)
The birth of immunoassayThe birth of immunoassay
• Rosalyn Yalow (1921-) and Solomon Berson described the first radioimmunoassay in 1957.
• Rosalyn Yalow (1921-) and Solomon Berson described the first radioimmunoassay in 1957.
![Page 6: Applications of Molecular Imprinting Technology to Immunoassays Roger L. Bertholf, Ph.D. Associate Professor of Pathology University of Florida Health](https://reader036.vdocument.in/reader036/viewer/2022070307/551a4e4d550346545e8b54e4/html5/thumbnails/6.jpg)
Fundamentals of antigen/antibody interactionFundamentals of antigen/antibody interaction
O
O-
O
O-
NH 3
+
CH2-CH2-CH2-CH3
OH
N
NH2
Cl
![Page 7: Applications of Molecular Imprinting Technology to Immunoassays Roger L. Bertholf, Ph.D. Associate Professor of Pathology University of Florida Health](https://reader036.vdocument.in/reader036/viewer/2022070307/551a4e4d550346545e8b54e4/html5/thumbnails/7.jpg)
Molecular imprinting (Step 1)Molecular imprinting (Step 1)
N
NO N
NH
O
H3C
CH3
N
NO N
NH
O
H3C
CH3
Methacrylic acid+ Porogen
![Page 8: Applications of Molecular Imprinting Technology to Immunoassays Roger L. Bertholf, Ph.D. Associate Professor of Pathology University of Florida Health](https://reader036.vdocument.in/reader036/viewer/2022070307/551a4e4d550346545e8b54e4/html5/thumbnails/8.jpg)
Molecular imprinting (Step 2)Molecular imprinting (Step 2)
N
NO N
NH
O
H3C
CH3
N
NO N
NH
O
H3C
CH3
![Page 9: Applications of Molecular Imprinting Technology to Immunoassays Roger L. Bertholf, Ph.D. Associate Professor of Pathology University of Florida Health](https://reader036.vdocument.in/reader036/viewer/2022070307/551a4e4d550346545e8b54e4/html5/thumbnails/9.jpg)
Molecular imprinting (Step 3)Molecular imprinting (Step 3)
N
NO N
NH
O
H3C
CH3
N
NO N
NH
O
H3C
CH3
Cross-linking monomerInitiating reagent
![Page 10: Applications of Molecular Imprinting Technology to Immunoassays Roger L. Bertholf, Ph.D. Associate Professor of Pathology University of Florida Health](https://reader036.vdocument.in/reader036/viewer/2022070307/551a4e4d550346545e8b54e4/html5/thumbnails/10.jpg)
Molecular imprinting (Step 4)Molecular imprinting (Step 4)
![Page 11: Applications of Molecular Imprinting Technology to Immunoassays Roger L. Bertholf, Ph.D. Associate Professor of Pathology University of Florida Health](https://reader036.vdocument.in/reader036/viewer/2022070307/551a4e4d550346545e8b54e4/html5/thumbnails/11.jpg)
Comparison of MIPs and antibodiesComparison of MIPs and antibodies
• In vivo preparation
• Limited stability
• Variable specificity
• General applicability
• In vivo preparation
• Limited stability
• Variable specificity
• General applicability
• In vitro preparation
• Unlimited stability
• Predictable specificity
• Limited applicability
• In vitro preparation
• Unlimited stability
• Predictable specificity
• Limited applicability
Antibodies MIPs
![Page 12: Applications of Molecular Imprinting Technology to Immunoassays Roger L. Bertholf, Ph.D. Associate Professor of Pathology University of Florida Health](https://reader036.vdocument.in/reader036/viewer/2022070307/551a4e4d550346545e8b54e4/html5/thumbnails/12.jpg)
Immunoassays using MIPsImmunoassays using MIPs
• Therapeutic Drugs: Theophylline, Diazepam, Morphine, Propranolol, Yohimbine (2-adrenoceptor antagonist)
• Hormones: Cortisol, Corticosterone
• Neuropeptides: Leu5-enkephalin
• Other: Atrazine, Methyl--glucoside
• Therapeutic Drugs: Theophylline, Diazepam, Morphine, Propranolol, Yohimbine (2-adrenoceptor antagonist)
• Hormones: Cortisol, Corticosterone
• Neuropeptides: Leu5-enkephalin
• Other: Atrazine, Methyl--glucoside
![Page 13: Applications of Molecular Imprinting Technology to Immunoassays Roger L. Bertholf, Ph.D. Associate Professor of Pathology University of Florida Health](https://reader036.vdocument.in/reader036/viewer/2022070307/551a4e4d550346545e8b54e4/html5/thumbnails/13.jpg)
AptamersAptamers
1014-1015 random sequences Target
Oligonucleotide-Target complex
Unbound oligonucleotides
Aptamer candidates
PCR
New oligonucleotide library
+ Target